In a surprising move, the CDC has appointed Retsef Levi, an anti-vaccine advocate, to lead a new COVID vaccine review group, raising concerns about the integrity of the review process. Experts fear the group may lack rigorous scientific standards.
In a surprising turn of events, the CDC has appointed Retsef Levi, known for his criticism of mRNA vaccines, to lead its COVID-19 immunization workgroup. This decision raises questions about vaccine safety and recommendations for children and pregnant women.
As RFK Jr. winds down mRNA vaccine research, experts warn America may lose its edge in vaccine development, putting public health at risk and ceding ground to adversaries like China.
In a surprising move, the Trump administration, under Robert F. Kennedy Jr., has canceled over $500 million in funding for mRNA vaccine development, raising alarms about America's future public health preparedness. Experts warn this could lead to dangerous vulnerabilities against infectious diseases.
The US government has made a controversial move by terminating $500 million in grants for mRNA vaccine research, a technology that saved millions during COVID-19. Experts warn this could hinder future health advancements.
In a surprising move, the US Department of Health has canceled contracts worth $500 million related to mRNA vaccine research, sparking concerns about future pandemic preparedness and the direction of vaccine technology.
HHS Secretary Robert F. Kennedy Jr. has sparked outrage by canceling $500 million in mRNA vaccine research grants, citing questionable data. Experts warn this could hinder public health efforts and the future of vaccine technology.
The NIH's Jay Bhattacharya argues that public distrust led to the cancellation of mRNA vaccine contracts. This statement contrasts with Health Secretary Kennedy's claims about vaccine safety and efficacy.
Former Surgeon General Dr. Jerome Adams warns that the U.S. risks lives by cutting funding for mRNA vaccine research, following Secretary Kennedy's controversial decision to halt key projects.
In a surprising move, U.S. health officials have canceled $500 million in mRNA vaccine research, citing studies that question their safety and effectiveness. Critics warn this decision undermines vital public health advancements made during the pandemic.
